ENZO BIOCHEM INC Quarterly Operating Lease, Right-of-Use Asset in USD from Q2 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Enzo Biochem Inc quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q2 2019 to Q3 2024.
  • Enzo Biochem Inc Operating Lease, Right-of-Use Asset for the quarter ending October 31, 2024 was $2.65M, a 22.1% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $2.65M -$751K -22.1% Oct 31, 2024 10-Q 2024-12-16
Q2 2024 $2.84M -$790K -21.8% Jul 31, 2024 10-Q 2024-12-16
Q1 2024 $2.96M -$10.5M -78% Apr 30, 2024 10-Q 2024-06-13
Q4 2023 $3.19M -$10.4M -76.5% Jan 31, 2024 10-Q 2024-03-13
Q3 2023 $3.41M -$11M -76.4% Oct 31, 2023 10-Q 2023-12-15
Q2 2023 $3.63M -$758K -17.3% Jul 31, 2023 10-K 2024-10-29
Q1 2023 $13.5M -$1.51M -10.1% Apr 30, 2023 10-Q 2023-06-14
Q4 2022 $13.6M -$1.84M -11.9% Jan 31, 2023 10-Q 2023-03-20
Q3 2022 $14.4M -$1.84M -11.3% Oct 31, 2022 10-Q 2022-12-12
Q2 2022 $4.38M -$12.6M -74.2% Jul 31, 2022 10-K 2023-11-03
Q1 2022 $15M -$2.45M -14.1% Apr 30, 2022 10-Q 2022-06-09
Q4 2021 $15.4M -$3.05M -16.5% Jan 31, 2022 10-Q 2022-03-14
Q3 2021 $16.3M -$3.06M -15.8% Oct 31, 2021 10-Q 2021-12-15
Q2 2021 $17M -$2.9M -14.5% Jul 31, 2021 10-K 2022-10-14
Q1 2021 $17.4M -$3.4M -16.3% Apr 30, 2021 10-Q 2021-06-11
Q4 2020 $18.5M -$3.55M -16.1% Jan 31, 2021 10-Q 2021-03-16
Q3 2020 $19.3M -$3.89M -16.7% Oct 31, 2020 10-Q 2020-12-11
Q2 2020 $19.9M -$4.48M -18.4% Jul 31, 2020 10-K 2021-10-12
Q1 2020 $20.8M Apr 30, 2020 10-Q 2020-06-09
Q4 2019 $22M Jan 31, 2020 10-Q 2020-03-06
Q3 2019 $23.2M Oct 31, 2019 10-Q 2019-12-10
Q2 2019 $24.4M Aug 1, 2019 10-K 2021-10-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.